Crossmark

Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015–2020 influenza seasons

Crossref DOI link: https://doi.org/10.1186/s12985-021-01739-1

Published Online: 2022-01-15

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Yafen

Wang, Yue

Mai, Huan

Chen, YuanYuan

Liu, Baiyi

Liu, YiSi

Ji, Ying

Cong, Xu

Gao, Yan https://orcid.org/0000-0002-7282-4530
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81541139)

Research and development fund of Peking University People’s Hospital (RD 2016-14)

Beijing key clinical specialty construction projects
License Information

Text and Data Mining valid from 2022-01-15

Version of Record valid from 2022-01-15
More Information

Article History

Received: 18 September 2021

Accepted: 30 December 2021

First Online: 15 January 2022

Declarations

:

: The study protocol was in accordance with the guidelines of the Declaration of Helsinki and was approved by the ethics committees of the Peking University People’s Hospital (PKUPH, IRB No. 2016PHB100-01). We explained the details of our study to each participant, and written informed consent was obtained from all participants prior to their inclusion in the study. Nasal samples and medical data were collected and analysed anonymously.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below